|
|
| (11) | Number of the document | C 1781688 |
| (68) | Number of the document | 1781688 |
| (21) | Application number for Supplementary Protection Certificate | PA 2016 010 |
| (22) | Date of filing the application | 2016-04-12 |
| (41) | Date of publication of the application | 2016-04-25 |
| Date of publication of SPC | 2017-09-25 | |
| (24) | Date of coming into effect of SPC | 2025-08-09 |
| (71) |
Onyx Therapeutics, Inc.,
249 E. Grand Avenue, South San Francisco, CA 94080,
US
|
| (73) |
Onyx Therapeutics, Inc.,
249 E. Grand Avenue, South San Francisco, CA 94080,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (93) | EU/1/15/1060, 2015-11-19 |
| (94) | 2030-08-08 |
| (95) | Karfilzomibas |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 1 | 347.00 EUR |
| 2026-08-09 |
| SPC granted |